Catalyst Pharmaceuticals
在场
高管
查看带有其 17 名主要高管的组织结构图
Catalyst Pharmaceuticals 搜索最多的简介
- Patrick McEnany, Non-Executive Chairman of the Board
- Richard Daly, Director and Chief Executive Officer
- David Tierney, Director
高管在Catalyst Pharmaceuticals变化
- Michael KalbMichael Kalb 将于20241月1作为 Executive Vice President and Chief Financial Officer 加入公司 (新闻发布的2023十二月5号).
- Alicia Grande, Vice President, Chief Financial Officer and Treasurer, 将于 202312月31 退休 (新闻发布的2023十二月5号).
- Richard Daly 曾任 Member of the Board, 将于 20241月1 升职为 Director and Chief Executive Officer (新闻发布的2023十月19号).
创建提醒
跟踪 Catalyst Pharmaceuticals 的高管变动
药店
Catalyst Pharmaceuticals 拥有 1,867 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。
Popular M&A news in 药店
- AstraZeneca has announced the acquisition of Fusion Pharma (公布2024三月23号).
- AstraZeneca has announced the acquisition of Amolyt Pharma (公布2024三月19号).
- Frontier Medicines 刚刚宣布为 80 筹款数百万美元。 (公布2024二月27号).
药店 行业的其他推荐联系人
消息
Catalyst Pharmaceuticals 的最新新闻稿
- Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual Healthcare Conference : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update : Catalyst Pharmaceutical
- Press Releases : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals Receives Two New U.S. Patent Allowances For FIRDAPSE® : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals Partners with Sofie's Journey to Bring Focus on Epilepsy at the 11th Annual Epilepsy Awareness and Education Expo : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 8, 2023 : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals Announces FDA Acceptance of the Supplemental New Drug Application for FIRDAPSE® : Catalyst Pharmaceutical
- Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer : Catalyst Pharmaceutical
- View more press releases Close
通过电子邮件
